Barbieri, Miriam

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping

Journal Article

Bains, Sahej; Giammarino, Lucilla; Nimani, Saranda; Alerni, Nicolo; Tester, David J; Kim, C S John; Christoforou, Nicolas; Louradour, Julien; Horváth, András; Beslac, Olgica; Barbieri, Miriam; Matas, Lluis; Hof, Thomas S.; Lopez, Ruben; Perez-Feliz, Stefanie; Parodi, Chiara; Garcia Casalta, Luisana G.; Jurgensen, Jacqulyn; Barry, Michael A; Bego, Mariana; ... (2024). KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome. European heart journal, 45(36), pp. 3751-3763. Oxford University Press 10.1093/eurheartj/ehae476

Crotti, Lia; Neves, Raquel; Dagradi, Federica; Musu, Giulia; Giannetti, Federica; Bos, J Martijn; Barbieri, Miriam; Cerea, Paolo; Giovenzana, Fulvio L F; Torchio, Margherita; Mura, Manuela; Gnecchi, Massimiliano; Conte, Giulio; Auricchio, Angelo; Sala, Luca; Odening, Katja E; Ackerman, Michael J; Schwartz, Peter J (2024). Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients. Circulation, 150(7), pp. 531-543. American Heart Association 10.1161/CIRCULATIONAHA.124.068959

Louradour, Julien; Ottersberg, Rahel; Segiser, Adrian; Olejnik, Agnieszka; Martinez-Salazar, Berenice; Siegrist, Mark; Egle, Manuel; Barbieri, Miriam; Nimani, Saranda; Alerni, Nicolò; Döring, Yvonne; Odening, Katja E.; Longnus, Sarah (2023). Simultaneous assessment of mechanical and electrical function in Langendorff-perfused ex-vivo mouse hearts. Frontiers in cardiovascular medicine, 10 Frontiers 10.3389/fcvm.2023.1293032

Giannetti, Federica; Barbieri, Miriam; Shiti, Assad; Casini, Simona; Sager, Philip T; Das, Saumya; Pradhananga, Sabindra; Srinivasan, Dinesh; Nimani, Saranda; Alerni, Nicolò; Louradour, Julien; Mura, Manuela; Gnecchi, Massimiliano; Brink, Paul; Zehender, Manfred; Koren, Gideon; Zaza, Antonio; Crotti, Lia; Wilde, Arthur A M; Schwartz, Peter J; ... (2023). Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2. Europace, 25(5) Oxford University Press 10.1093/europace/euad094

Provide Feedback